These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6824849)

  • 41. Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion.
    Caudarella R; Stefani F; Rizzoli E; Malavolta N; D'Antuono G
    J Urol; 1983 Mar; 129(3):665-7. PubMed ID: 6834573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A method for discrimination between calcium oxalate kidney stone formers and normals.
    Sarig S; Garti N; Azoury R; Wax Y; Perlberg S
    J Urol; 1982 Sep; 128(3):645-9. PubMed ID: 6214645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Idiopathic hypercalciuria. Urate and other ions in urine before and on various long term treatments.
    Gill HS; Rose GA
    Urol Res; 1985; 13(6):271-5. PubMed ID: 4095826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dietary control for out-patients in urinary stone clinic].
    Kato T; Yanagawa M; Hioki T; Sakurai M; Yamakawa K; Araki T; Yamamoto I; Arima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1993 Jul; 39(7):593-8. PubMed ID: 8362676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seasonal variations in the composition of urine in relation to calcium stone-formation.
    Robertson WG; Peacock M; Marshall RW; Speed R; Nordin BE
    Clin Sci Mol Med; 1975 Dec; 49(6):597-602. PubMed ID: 1172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of intestinal surgery on the risk of urinary stone formation.
    Bambach CP; Robertson WG; Peacock M; Hill GL
    Gut; 1981 Apr; 22(4):257-63. PubMed ID: 7239317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
    Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between 1,25-dihydroxyvitamin-D, calcium and uric acid in urinary stone formers.
    Jarrar K; Amasheh RA; Graef V; Weidner W
    Urol Int; 1996; 56(1):16-20. PubMed ID: 8903548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Who makes uric acid stones and why--observations from a renal stones clinic.
    Stansbridge EM; Griffin DG; Walker V
    J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL; Marshall VR
    Clin Chim Acta; 1984 Aug; 141(2-3):197-204. PubMed ID: 6488555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.